A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Sulfacytine
Potassium bitartrate
Potassium bitartrate may increase the hyperkalemic activities of Canagliflozin.
Sulfacytine
Potassium alum
Potassium alum may increase the hyperkalemic activities of Canagliflozin.
Sulfacytine
Metreleptin
The metabolism of Canagliflozin can be increased when combined with Metreleptin.
Sulfacytine
Abemaciclib
The serum concentration of Abemaciclib can be increased when it is combined with Canagliflozin.
Sulfacytine
Binimetinib
The serum concentration of Binimetinib can be increased when it is combined with Canagliflozin.
Sulfacytine
Bendamustine
The serum concentration of Bendamustine can be increased when it is combined with Canagliflozin.
Sulfacytine
Copanlisib
The serum concentration of Copanlisib can be increased when it is combined with Canagliflozin.
Sulfacytine
Dacomitinib
The serum concentration of Dacomitinib can be increased when it is combined with Canagliflozin.
Sulfacytine
Talazoparib
The serum concentration of Talazoparib can be increased when it is combined with Canagliflozin.
Sulfacytine
Vinflunine
The serum concentration of Vinflunine can be increased when it is combined with Canagliflozin.
Sulfacytine
Venetoclax
The serum concentration of Venetoclax can be increased when it is combined with Canagliflozin.
Sulfacytine
Osimertinib
The serum concentration of Osimertinib can be increased when it is combined with Canagliflozin.
Sulfacytine
Ceritinib
The serum concentration of Ceritinib can be increased when it is combined with Canagliflozin.
Sulfacytine
Dabrafenib
The serum concentration of Dabrafenib can be increased when it is combined with Canagliflozin.
Sulfacytine
Pomalidomide
The serum concentration of Pomalidomide can be increased when it is combined with Canagliflozin.
Sulfacytine
Permethrin
Permethrin may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Bepotastine
Bepotastine may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Potassium cation
Potassium cation may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Strontium chloride
Canagliflozin may increase the excretion rate of Strontium chloride which could result in a lower serum level and potentially a reduction in efficacy.
Sulfacytine
Lithium hydroxide
Canagliflozin may increase the excretion rate of Lithium hydroxide which could result in a lower serum level and potentially a reduction in efficacy.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3